The veterinary medicine and pharmaceuticals landscape is evolving rapidly, driven by innovation, shifting market demands, high costs, and global challenges.
In this article, we’re highlighting how these developments are shaping the future of veterinary care, and how Raman Pharma is leading the charge in supporting practices with these changes.
Oncology medicines for veterinary use
Cancer treatment in animals has traditionally lagged behind that of humans, but this is beginning to change. Veterinary oncology is gaining momentum, with pharmaceutical companies investing in the development of new cancer therapies specifically designed for pets. With more advanced diagnostic tools available to veterinarians, earlier detection of cancer in animals has become possible, leading to an increased demand for effective treatments.
One of the most exciting advancements is the development of targeted therapies, similar to those used in human oncology, which offer more personalised treatment options with fewer side effects. Immunotherapy and precision medicine are also on the rise, offering hope to pet owners looking to provide their animals with the best care available.
Supplying the largest selection of oncology drugs for vets in the UK, Raman Pharma has taken an active involvement in this growing field. We’re importing both human and animal oncology medicines, ensuring treatments are accessible for the patients that need them most.
Shortage of human medicines and the veterinary impact
A global shortage of human medicines, driven by supply chain disruptions and increased demand, is impacting practices across the UK. Many veterinary treatments rely on the same medications used in human medicine, especially for pain management, antibiotics, and certain critical care products. As these shortages persist, veterinarians are facing challenges in sourcing essential treatments.
Raman Pharma is stepping in to provide vital support by helping customers find alternative solutions when human medicines are out of stock or difficult to source. By leveraging our extensive network of suppliers and deep industry expertise, we do all we can to find suitable, high-quality alternatives, ensuring that pets and livestock continue to receive the care they need without interruption.
High costs and the impact of CMA investigations
Rising costs are becoming a significant concern in the pharmaceuticals sector. As the costs of developing new medicines, raw materials, and regulatory compliance continue to increase, so do the prices of treatments. This places added pressure on both veterinary practices and pet owners, who may struggle to afford the care their animals need. The situation has raised concerns about transparency and fair pricing within the industry, prompting investigations by bodies such as the Competition and Markets Authority (CMA).
The CMA has recently launched investigations into price-setting practices and the competitive landscape of pharmaceuticals to ensure fair competition and prevent price inflation from burdening consumers. These investigations are expected to bring greater transparency and potentially drive down costs, benefiting pet owners, veterinarians, and businesses alike.
Experiencing the importance of cost-effective solutions on a daily basis, Raman Pharma is committed to helping veterinary professionals source competitively priced medicines without compromising on quality.
Growth in preventative care
Preventative care is becoming a significant trend, as pet owners are increasingly focused on maintaining the overall health and well-being of their animals. This includes regular wellness checks, vaccinations, and the use of supplements to boost immune function and prevent chronic illnesses. As a result, there is a rising demand for preventative medicines and nutraceuticals, which are tailored to improving long-term health outcomes for pets and livestock.
Veterinary professionals are embracing a more holistic approach to care, addressing not only immediate medical needs but also recommending preventative treatments to enhance quality of life.
Sustainable pharmaceuticals
Sustainability is becoming a central concern, as both veterinarians and pet owners are increasingly aware of the environmental impact of pharmaceutical production and waste. Companies are now focusing on producing more eco-friendly medicines, packaging, and supply chains to reduce their environmental footprint. Sustainable practices, including reducing chemical waste, recycling packaging, and utilising greener manufacturing methods, are becoming key differentiators in the industry.
Future outlook
The pharmaceutical landscape is undergoing significant transformation, highlighting the need for flexibility and forward-thinking solutions. The team here at Raman Pharma are committed to helping veterinary professionals navigate these changes, ensuring that all animals receive the best possible care.
To find out more about how Raman Pharma can help your practice, give us a call on 01252 260460 or email sales@ramanpharma.com.